Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism

Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xueyuan Yang, Bangjian Dong, Lijun An, Qi Zhang, Yao Chen, Honglin Wang, Ziteng Song
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6a8edb6264dd41349f8eb9444e748381
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a8edb6264dd41349f8eb9444e748381
record_format dspace
spelling oai:doaj.org-article:6a8edb6264dd41349f8eb9444e7483812021-11-30T18:59:52ZGinsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism1663-981210.3389/fphar.2021.756491https://doaj.org/article/6a8edb6264dd41349f8eb9444e7483812021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.756491/fullhttps://doaj.org/toc/1663-9812Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elusive in detail. In this study, we investigated the impact of Rb1 oral supplementation on high fat diet (HFD) induced obesity mice, and explored its mechanism in regulating blood glucose. The results showed that higher liver weight and lower cecum weight were observed in HFD fed mice, which was maintained by Rb1 administration. In addition, Rb1 ameliorated HFD induced blood lipid abnormality and improved insulin sensitivity. Several mRNA expressions in the liver were measured by quantitative real-time PCR, of which UCP2, Nr1H4, and Fiaf were reversed by Rb1 treatment. 16S rRNA sequencing analysis indicated that Rb1 significantly altered gut microbiota composition and increased the abundance of mucin-degrading bacterium Akkermansia spp. compared to HFD mice. As suggested via functional prediction, amino acid metabolism was modulated by Rb1 supplementation. Subsequent serum amino acids investigation indicated that several diabetes associated amino acids, like branched-chain amino acids, tryptophan and alanine, were altered in company with Rb1 supplementation. Moreover, correlation analysis firstly implied that the circulation level of alanine was related to Akkermansia spp.. In summary, Rb1 supplementation improved HFD induced insulin resistance in mice, and was associated with profound changes in microbial composition and amino acid metabolism.Xueyuan YangBangjian DongBangjian DongLijun AnQi ZhangYao ChenHonglin WangZiteng SongFrontiers Media S.A.articleginsenoside Rb1insulin sensitivitygut microbiotaamino acid metabolismcorrelation analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic ginsenoside Rb1
insulin sensitivity
gut microbiota
amino acid metabolism
correlation analysis
Therapeutics. Pharmacology
RM1-950
spellingShingle ginsenoside Rb1
insulin sensitivity
gut microbiota
amino acid metabolism
correlation analysis
Therapeutics. Pharmacology
RM1-950
Xueyuan Yang
Bangjian Dong
Bangjian Dong
Lijun An
Qi Zhang
Yao Chen
Honglin Wang
Ziteng Song
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
description Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elusive in detail. In this study, we investigated the impact of Rb1 oral supplementation on high fat diet (HFD) induced obesity mice, and explored its mechanism in regulating blood glucose. The results showed that higher liver weight and lower cecum weight were observed in HFD fed mice, which was maintained by Rb1 administration. In addition, Rb1 ameliorated HFD induced blood lipid abnormality and improved insulin sensitivity. Several mRNA expressions in the liver were measured by quantitative real-time PCR, of which UCP2, Nr1H4, and Fiaf were reversed by Rb1 treatment. 16S rRNA sequencing analysis indicated that Rb1 significantly altered gut microbiota composition and increased the abundance of mucin-degrading bacterium Akkermansia spp. compared to HFD mice. As suggested via functional prediction, amino acid metabolism was modulated by Rb1 supplementation. Subsequent serum amino acids investigation indicated that several diabetes associated amino acids, like branched-chain amino acids, tryptophan and alanine, were altered in company with Rb1 supplementation. Moreover, correlation analysis firstly implied that the circulation level of alanine was related to Akkermansia spp.. In summary, Rb1 supplementation improved HFD induced insulin resistance in mice, and was associated with profound changes in microbial composition and amino acid metabolism.
format article
author Xueyuan Yang
Bangjian Dong
Bangjian Dong
Lijun An
Qi Zhang
Yao Chen
Honglin Wang
Ziteng Song
author_facet Xueyuan Yang
Bangjian Dong
Bangjian Dong
Lijun An
Qi Zhang
Yao Chen
Honglin Wang
Ziteng Song
author_sort Xueyuan Yang
title Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
title_short Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
title_full Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
title_fullStr Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
title_full_unstemmed Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
title_sort ginsenoside rb1 ameliorates glycemic disorder in mice with high fat diet-induced obesity via regulating gut microbiota and amino acid metabolism
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6a8edb6264dd41349f8eb9444e748381
work_keys_str_mv AT xueyuanyang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT bangjiandong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT bangjiandong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT lijunan ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT qizhang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT yaochen ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT honglinwang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
AT zitengsong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism
_version_ 1718406329945554944